Darko Antic, PhD1,2*, Natasa Milic3*, Thomas Chatzikonstantinou4,5*, Lydia Scarfo, MD6*, Vladimir Otasevic, MD2*, Nina Rajovic3*, David Allsup7*, Alejandro Alonso Cabrero8*, Martin Andres9*, Monica Baile Gonzales10*, Antonella Capasso11*, Rosa Collado12,13*, Raul Cordoba, MD, PhD14, Carolina Cuéllar-García15*, Juan Gonzalo Correa16*, Lorenzo De Paoli17*, Maria Rosaria De Paolis18*, Giovanni Del Poeta, MD19*, Maria Dimou20, Michael Doubek, MD, PhD21,22, Maria Efstathopoulou23*, Shaimaa El-Ashwah24*, Alicia Enrico25*, Blanca Espinet, PhD26*, Lucia Farina27*, Angela Ferrari28*, Myriam Foglietta29*, Alberto Lopez-Garcia14*, Jose A. Garcia-Marco30, Rocío García-Serra12,13*, Massimo Gentile, MD31*, Eva Gimeno26*, Maria Gomes da Silva32*, Odit Gutwein33,34*, Yervand Hakobyan35*, Yair Herishanu36*, José Ángel Hernández-Rivas37*, Tobias Herold, MD38, Gilad Itchaki39*, Ozren Jaksic, MD, PhD40, Ann Janssens, MD, PhD41*, Оlga B. Kalashnikova42*, Elżbieta Kalicińska43*, Arnon P. Kater, MD, PhD44, Sabina Kersting, MD, PhD45*, Maya Koren-Michowitz, MD34,46, Jorge Labrador Gomez47*, Deepesh Lad48*, Luca Laurenti, MD49,50*, Alberto Fresa, MD49,51*, Mark-David Levin52, Carlota Mayor Bastida8,53*, Lara Malerba54*, Roberto Marasca, MD55, Monia Marchetti56*, Juan Marquet57*, Biljana Mihaljevic1,2*, Ivana Milosevic58*, Fatima Mirás59*, Marta Morawska60,61*, Marina Motta, MD62*, Talha Munir, MBBS, MRCP, FRCPath, PhD63*, Roberta Murru, MD64*, Raquel Nunes65*, Jacopo Olivieri66*, Miguel Arturo Pavlovsky67, Inga S. Piskunova68*, Viola Maria Popov69*, Francesca Maria Quaglia70*, Giulia Quaresmini71*, Gianluigi Reda, MD72*, Gian Matteo Rigolin73*, Amit Shrestha74*, Martin Šimkovič75*, Svetlana Smirnova68*, Martin Špaček76*, Paolo Sportoletti, MD77*, Oana Stanca78*, Niki Stavroyianni79*, Doreen Te Raa80*, Kristina Tomic2*, Sanne Tonino81*, Livio Trentin82, Ellen Van Der Spek83*, Michel van Gelder84, Marzia Varettoni, MD85*, Andrea Visentin, MD, PhD82*, Candida Vitale86*, Vojin Vukovic2*, Ewa Wasik-Szczepanek87*, Tomasz Wróbel88, Lucrecia Yanez San Segundo89, Mohamed A Yassin, MBBS, MSC, CABM, MSC, FACP90, Marta Coscia91*, Alessandro Rambaldi, MD71, Emili Montserrat16*, Robin Foà92*, Antonio Cuneo73*, Marc Carrier, MD, MSc93, Paolo Ghia, MD, PhD94 and Kostas Stamatopoulos, MD4
1Faculty of Medicine, University of Belgrade, Belgrade, Serbia
2Lymphoma Center, Clinic for Hematology, University Clinical Center of Serbia, Belgrade, Serbia
3Department of Medical Statistics and Informatics, Medical Faculty, University of Belgrade, Belgrade, Serbia
4Institute of Applied Biosciences, Centre for Research and Technology Hellas, Thessaloniki, Greece
5Hematology Department and HCT Unit, G. Papanikolaou Hospital, Thessaloniki, Greece
6Università Vita-salute San Raffaele and IRCC Ospedale San Raffaele, Milan, Italy
7Centre for Atherothrombosis and Metabolic Disease, Hull York Medical School, Hull, ENG, United Kingdom
8Haematology department, Hospital Universitario de La Princesa, Madrid, Spain
9Department of Hematology and Central Hematology Laboratory, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland
10Hematology Department. University Hospital of Salamanca-IBSAL, Salamanca, Spain
11IRCCS Ospedale San Raffaele, Milano, Italy
12Department of Hematology, Hospital General Universitario, Valencia, Spain
13Fundación de Investigación del Hospital General Universitario, Valencia, Spain
14Department of Hematology, Health Research Institute IIS-FJD, Fundacion Jimenez Diaz University Hospital, Madrid, Spain
15Hematology Unit Terrassa Hospital, Terrasa, Spain
16Hospital Clínic de Barcelona, Barcelona, Spain
17Division of Internal Medicine, Hematology Unit, ASL Vercelli, Vercelli, Italy
18UOC Ematologia PO Vito Fazzi Lecce, Lecce, Italy
19Hematology, Department of Biomedicine, University Tor Vergata Roma, Italy, Rome, Italy
201st Internal Medicine Department, Propaedeutic, Hematology Clinical Trial Unit, National and Kapodistrian University of Athens, Athens, Greece
21Department of Internal Medicine - Hematology and Oncology, Medical Faculty MU and University Hospital Brno, Brno, Czech Republic
22Department of Internal Medicine - Hematology and Oncology, University Hospital and Faculty of Medicine, Masaryk University, Brno, Czech Republic
23Department of Haematology Athens Medical Center-Psychikon Branch, Athens, Greece
24Clinical Hematology Unit, Oncology Center, Faculty of Medicine, Mansoura University, Mansoura 35516, Egypt
25Hospital Italiano La Plata, La Plata, Argentina
26Department of Hematology, Hospital del Mar, Barcelona, Spain
27Hematology, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy
28Hematology Unit, Azienda Unità Sanitaria Locale – IRCCS, Reggio Emilia, Italy
29SC Ematologia, AO S. Croce e Carle, Cuneo, Italy
30Hematology Department, Hospital Universitario Puerta de Hierro-Majadahonda, Majadahonda, Spain
31Hematology Unit AO Cosenza, Cosenza, Italy
32Department of Hematology, Instituto Português de Oncologia de Lisboa, Lisbon, Portugal
33Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
34Department of Hematology, Shamir Medical Center, Zerifin, Israel
35Hematology Center after Prof. Yeolyan MH RA, Yerevan, Armenia
36Tel-Aviv Sourasky Medical Center and Sackler School of Medicine, Tel Aviv University, Tel-Aviv, ISR
37Department of Hematology, Infanta Leonor University Hospital, Madrid, Spain
38Laboratory for Leukemia Diagnostics, Department of Medicine III, Ludwig-maximilians-Universitaet (LMU), Munich, Bavaria, Germany
39Division of Hematology, Rabin Medical Center, Petah Tikva, and the Sackler School of Medicine, Tel-Aviv University, Petah Tikva, Israel
40Division of Hematolog, Dubrava University Hospital, Zagreb, Croatia
41Department of Hematology, Universitaire Ziekenhuizen Leuven, Leuven, Belgium
42Federal State Budgetary Educational Institution of Higher Education Academician I.P. Pavlov First St. Petersburg State Medical University of the Ministry of Healthcare of Russian Federation, St. Petersburg, Russian Federation
43Department and Clinic of Hematology, Blood Neoplasms and Bone Marrow Transplantation Wroclaw Medical University, Pasteura Street 4, 50-367 Wrocław, Poland
44Dept of Hematology, Cancer Center Amsterdam, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, Netherlands
45Department of Hematology, Haga Teaching Hospital, The Hague, Netherlands
46Sackler School of Medicine, Tel-Aviv University, Tel-Aviv, Israel
47Hematology Department, Unit Research, Complejo Asistencial Universitario de Burgos, Burgos, Spain
48Department of Internal Medicine, Postgraduate Institute of Medical Education and Research, Chandigarh, India
49Sezione di Ematologia, Dipartimento di Scienze Radiologiche ed Ematologiche, Università Cattolica del Sacro Cuore, Rome, Italy
50Dipartimento di Diagnostica per Immagini, Radioterapia Oncologica ed Ematologia, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Roma, Italy
51Dipartimento di Diagnostica per Immagini, Radioterapia Oncologica ed Ematologia, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy
52Department of Internal Medicine, Albert Schweitzer hospital, Dordrecht, Netherlands
53Spanish Society of Haematology and hemotherapy (SEHH: Sociedad Española de Hematología y hemoterapia), Madrid, Spain
54Hematology and Stem Cell Transplant Center Marche Nord Hospital, Pesaro, Italy
55Dept of Medical Sciences, Section of Hematology, University of Modena and Reggio Emilia, Modena, Italy
56Hematology Unit & TMO Center, AO SS Antonio e Biagio e Cesare Arrigo, Alessandria, Italy
57Hematology Department Ramón y Cajal University Hospital, Madrid, Spain
58University of Novi Sad, Faculty of Medicine, Clinical Centre of Vojvodina, Novi Sad, Serbia
59Hematology Department Hospital Universitario 12 de Octubre, Madrid, Spain
60Experimental Hematooncology Department, Medical University of Lublin, Lublin, Poland
61Hematology Department, St. John's Cancer Center, Lublin, Poland
62S.C. Ematologia ASST Spedali Civili, Brescia, Italy
63Consultant Haematologist, St James's Hospital, Leeds, United Kingdom
64Hematology and Stem Cell Transplantation Unit, Ospedale Oncologico A. Businco, ARNAS G. Brotzu, Cagliari, Italy
65Hematology Department, Portuguese Institute of Oncology, Lisbon, Portugal
66Hematology Clinic, ASUFC, Udine, Italy
67FUNDALEU, Clinical research center Buenos Aires, Buenos Aires, Argentina
68Consultative Hematology Department with a Day Hospital for Intensive High-Dose Chemotherapy, National Research Center for Hematology, Moscow, Russian Federation
69Hematology Department Colentina Clinical Hospital, Bucharest, Romania
70Department of Medicine, Section of Hematology, University of Verona, Verona, Italy
71Hematology, ASST Papa Giovanni XXIII, Bergamo, Italy
72Hematology unit, Hematology Unit, Foundation IRCCS Ca’ Granda Ospedale Maggiore Policlinico of Milan, Milan, Italy
73St. Anna University Hospital, Ferrara, Italy
74Hematology Unit, Nepal Cancer Hospital & Research Center, Lalitpur, Nepal
754th Department of Internal Medicine – Haematology, Faculty of Medicine in Hradec Králové, University Hospital and Charles University in Prague, Hradec Kralove, Czech Republic
761st Department of Medicine - Hematology, First Faculty of Medicine, Charles University and General Hospital in Prague, Prague, Czech Republic
77Department of Medicine and Surgery, Institute of Hematology and Center for Hemato-Oncological Research, Ospedale S. Maria della Misericordia, Perugia, Italy
78"Carol Davila" University of Medicine and Pharmacy - Hematology Department from Coltea Clinical Hospital, Bucharest, Romania
79Hematology Department and HCT Unit, G. Papanicolaou Hospital, Thessaloniki, Greece
80Department of hematology, Gelderse Vallei Ede, Ede, Netherlands
81Dept of Hematology, Lymmcare, Cancer Center Amsterdam, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, Netherlands
82Hematology and Clinical Immunology Unit, Department of Medicine, University of Padova, Padova, Italy
83Rijnstate hospital, department of internal medicine Arnhem, Arnhem, Netherlands
84Dept internal medicine, Maastricht University Medical Center, Maastricht, Netherlands
85Division of Hematology Fondazione IRCCS Policlinico San Matteo, Pavia, Italy
86Division of Hematology, A.O.U. Cittàdella Salute e dellaScienza di Torino and Department of Molecular Biotechnology and Health Sciences, University of Turin, Turin, TX, Italy
87Dept. Hematooncology and Bone Marrow Transplantation Medical University in Lublin, Lublin, Poland
88Department and Clinic of Hematology, Blood Neoplasms and Bone Marrow Transplantation Wroclaw Medical University, Wroclaw, Poland
89University Hospital and Research Institute of Marqués de Valdecilla (IDIVAL), Santander, Spain
90Department of Medical Oncology/ Hematology Section, National Centre For Cancer Care & Research, Doha, Qatar
91Division of Hematology, A.O.U. Cittàdella Salute e dellaScienza di Torino and Department of Molecular Biotechnology and Health Sciences, University of Turin, Turin, Italy
92Hematology, Department of Translational and Precision Medicine, Sapienza University, Rome, Italy
93Department of Medicine, Ottawa Hospital Research Institute, University of Ottawa, Ottawa, ON, Canada
94Universita' Vita-Salute San Raffaele C.F. 97187560152, Milano, MI, Italy
Disclosures: Scarfo: AbbVie, AstraZeneca, Janssen, Beigene, Lilly: Honoraria; BeiGene, Janssen: Other: Travel Grant; Octapharma: Speakers Bureau. Cordoba: Janssen: Other: Speaker; Astra Zeneca: Other: Speaker; Lilly: Consultancy; Beigene: Consultancy; Janssen: Consultancy; Astra Zeneca: Consultancy. Doubek: AOP Orphan: Consultancy, Research Funding; AbbVie: Honoraria; AstraZeneca: Consultancy, Honoraria, Research Funding; Janssen: Honoraria. García-Serra: Novartis: Other: received educational activity; Abbvie: Other: received educational activity. Gomes da Silva: Gilead Genesis: Research Funding; AstraZeneca: Research Funding; Janssen, Gilead Sciences, MSD, Celgene, Roche, Takeda, Novartis, ADC Therapeutics: Consultancy; Roche: Membership on an entity's Board of Directors or advisory committees; Janssen: Speakers Bureau. Hernández-Rivas: Rovi: Membership on an entity's Board of Directors or advisory committees; Roche: Membership on an entity's Board of Directors or advisory committees, Speakers Bureau; Jazz Pharmaceuticals: Membership on an entity's Board of Directors or advisory committees; Janssen: Membership on an entity's Board of Directors or advisory committees, Speakers Bureau; Incyte: Membership on an entity's Board of Directors or advisory committees; Gilead: Membership on an entity's Board of Directors or advisory committees, Speakers Bureau; Beigene: Membership on an entity's Board of Directors or advisory committees; BMS/Celgene: Membership on an entity's Board of Directors or advisory committees, Speakers Bureau; AstraZeneca: Membership on an entity's Board of Directors or advisory committees, Speakers Bureau; Amgen: Membership on an entity's Board of Directors or advisory committees, Speakers Bureau; Abbvie: Membership on an entity's Board of Directors or advisory committees, Speakers Bureau; Takeda: Speakers Bureau; Lilly: Membership on an entity's Board of Directors or advisory committees. Itchaki: AstraZeneca: Consultancy; Abbvie: Consultancy; Janssen: Consultancy. Jaksic: Johnson and Johnson: Speakers Bureau; Abbvie: Speakers Bureau; Astra Zeneca: Consultancy, Speakers Bureau. Janssens: Genmab: Current Employment; Abbvie: Consultancy, Other: Travel Grants, Speakers Bureau; Amgen: Consultancy, Other: travel grants, Speakers Bureau; Astra-Zeneca: Consultancy, Speakers Bureau; Beigene: Consultancy, Speakers Bureau; Janssen: Consultancy, Speakers Bureau; Incyte: Consultancy, Speakers Bureau; Novartis: Consultancy, Speakers Bureau; Sobi: Consultancy, Speakers Bureau; Sanofi Genzyme: Consultancy, Speakers Bureau; Roche: Consultancy; Celgene: Other: travel grants. Kater: Astra Zeneca, BMS, Roche/Gennetech, Janssen, Abbvie, LAVA: Membership on an entity's Board of Directors or advisory committees; Janssen, LAVA: Patents & Royalties: Pending; Abbvie, Astra Zeneca, BMS, Janssen, Roche/Genentech: Research Funding; Abbvie, Astra Zeneca, Janssen: Other: Speakers fee; Amsterdam UMC, University of Amsterdam: Current Employment. Levin: AbbVie, Roche and Janssen: Other: Travel expenses. Munir: Janssen, AstraZeneca, Alexion, Sobi, Novartis, Roche, Abbvie, Gilead: Honoraria; Janssen, AstraZeneca, Alexion, Abbvie, Novartis, Roche: Membership on an entity's Board of Directors or advisory committees. Pavlovsky: AstraZeneca: Membership on an entity's Board of Directors or advisory committees; Raffo: Membership on an entity's Board of Directors or advisory committees; AstraZeneca: Other; AbbVie: Other: Conference; Janssen: Other: Conference; Janssen: Membership on an entity's Board of Directors or advisory committees; AbbVie: Membership on an entity's Board of Directors or advisory committees. Reda: Janssen, Abbive, Astra Zeneca, Beigene: Consultancy. Rigolin: Abbvie: Honoraria; AstraZeneca: Honoraria; Janssen: Honoraria; Gilead: Honoraria, Research Funding. Šimkovič: Janssen-Cilag, Gilead, Roche, AstraZeneca, Abbvie: Consultancy, Honoraria, Membership on an entity's Board of Directors or advisory committees, Other: Travel Grants. Tonino: Roche: Honoraria; Incyte: Honoraria; Takeda: Honoraria. Varettoni: ABBVIE: Honoraria, Membership on an entity's Board of Directors or advisory committees, Other: travel expenses; ASTRAZENECA: Membership on an entity's Board of Directors or advisory committees; BEIGENE: Membership on an entity's Board of Directors or advisory committees, Other: travel expenses; JANNSEN: Membership on an entity's Board of Directors or advisory committees, Other: travel expenses. Visentin: Janssen, Abbvie, CSL Behring: Consultancy, Membership on an entity's Board of Directors or advisory committees, Speakers Bureau; Beigene: Membership on an entity's Board of Directors or advisory committees, Research Funding; AstraZeneca: Consultancy; Gilead: Consultancy; Takeda: Consultancy, Membership on an entity's Board of Directors or advisory committees, Research Funding. Wróbel: GSK: Honoraria; Janssen: Honoraria; Amgen: Honoraria, Research Funding; Takeda: Honoraria; Beigene: Honoraria; Novartis: Honoraria; Abbvie: Honoraria; Gilead: Honoraria; Celgen/BMS: Honoraria; Roche: Honoraria, Research Funding. Rambaldi: Amgen: Honoraria; Pfizer: Honoraria; Astellas: Honoraria; ABBVIE: Honoraria; Jazz: Honoraria; Kite-Gilead: Honoraria; Novartis: Honoraria; Incyte: Honoraria; Roche: Honoraria; Janssen: Honoraria; Celgene-BMS: Honoraria; Omeros: Honoraria. Carrier: Pfizer: Consultancy, Honoraria, Research Funding; Sanofi: Consultancy; BMS: Consultancy, Honoraria, Research Funding; Bayer: Consultancy, Honoraria; Servier: Consultancy, Honoraria; Leo Pharma: Consultancy, Honoraria, Research Funding. Ghia: MSD: Consultancy, Honoraria; Roche: Consultancy, Honoraria; AbbVie: Consultancy, Honoraria, Research Funding; AstraZeneca: Consultancy, Honoraria, Research Funding; Janssen: Consultancy, Honoraria, Research Funding; BeiGene: Consultancy, Honoraria; BMS: Consultancy, Honoraria; Lilly/Loxo: Consultancy, Honoraria. Stamatopoulos: Janssen: Research Funding; AbbVie: Research Funding.